UBS lowered the firm’s price target on Progressive (PGR) to $280 from $291 and keeps a Neutral rating on the shares. P&C Insurance stocks under coverage were down 4% in 2Q25, on average, reflecting less favorable fundamentals and a shift from defensive stocks to more economically sensitive stocks, the analyst tells investors in a research note. UBS favors Personal lines insurers into 2Q25 results where margins remain attractive.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGR:
- Is PGR a Buy, Before Earnings?
- Progressive price target raised to $337 from $333 at BofA
- Progressive’s Undervalued Stock and Growth Potential: A Buy Recommendation by Joshua Shanker
- Progressive price target lowered to $287 from $297 at Barclays
- Hold Rating for Progressive Amidst Competitive Pressures and Valuation Concerns